Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research ...

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...

Citi views the recent volatility in shares of Royalty Pharma (RPRX) as a buying opportunity. Worries over the tariff impact to biopharma have ...

Avecho (ASX:AVE) has received a US$3 million (A$4.7 million) payment from pharma heavyweight Sandoz in exchange for the ...

Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Could Dr. Oz use a post as head of the federal agency that oversees Medicare, Medicaid and HealthCare.gov to promote the iHerb online herbal supplements market? Sen. Elizabeth Warren, D-Mass.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Germany’s Heidelberg Pharma (FSE: HPHA) has modified its royalty financing agreement with HealthCare Royalty (HCRx), securing an additional $20 million upfront payment. The amendment extends the ...

This guide covers all the logo design rules, best practices, tips, examples, and more to equip you with the knowledge for crafting brilliant logos. Logos are one of the most vital elements of any ...

View Our Latest Report on Royalty Pharma Royalty Pharma Price Performance Shares of NASDAQ RPRX opened at $32.75 on Tuesday. The firm has a market cap of $18.88 billion, a PE ratio of 22.59, a PEG ...